Ml. Vanderwalt et As. Greeff, THE PRODUCTION OF AN AUXOTROPHIC MARKED, PLASMID-CURED SALMONELLA SER. TYPHIMURIUM AS A LIVE ATTENUATED VACCINE, Onderstepoort journal of veterinary research, 65(3), 1998, pp. 213-220
A number of amino acid requiring auxotrophic strains of Salmonella Typ
himurium were produced by chemical mutagenesis. One of them, strain 81
, was cured of the virulence plasmid and attenuated for mice. This str
ain had an auxotrophic requirement for serine, which could be used as
a marker for the differentiation of the vaccine strain from other isol
ates in the field. The strain still contained the smooth form of the O
-antigen, was resistant to Complement-mediated killing of serum and pr
oduced type 1 fimbriae. Of the six auxotrophic mutants only this mutan
t differed in its outer membrane protein profile from that of the pare
nt strain in that an outer membrane protein of about 30 kDa was absent
. With the use of the polymerase chain reaction, using total DNA of th
e cell as template, and with primers targeted to the virulence plasmid
, it was shown that the virulence plasmid of Salmonella Typhimurium wa
s completely cured from this strain. This strain also had a LD50-value
of 4 log units lower for mice than the parent strain. The plasmid-cur
ed strain gave a very high degree of protection to mice after systemic
immunization, but not after oral vaccination. Compared to the parent,
strain 81 also had a lower multiplication rate in the liver and splee
n after intraperitoneal inoculation, characteristics that could be att
ributed to plasmid-loss, and it could also not be recovered from the s
pleen and liver of orally inoculated mice.